Advertisement
UK markets close in 5 hours
  • FTSE 100

    8,087.69
    +47.31 (+0.59%)
     
  • FTSE 250

    19,716.89
    -2.48 (-0.01%)
     
  • AIM

    755.26
    +0.57 (+0.08%)
     
  • GBP/EUR

    1.1667
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2516
    +0.0054 (+0.43%)
     
  • Bitcoin GBP

    50,732.92
    -2,291.32 (-4.32%)
     
  • CMC Crypto 200

    1,354.41
    -28.17 (-2.04%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.83
    +0.02 (+0.02%)
     
  • GOLD FUTURES

    2,337.60
    -0.80 (-0.03%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,971.89
    -116.81 (-0.65%)
     
  • CAC 40

    8,035.49
    -56.37 (-0.70%)
     

These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?

These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?

In the past two years, biotech companies Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) rose to fame thanks to their successful attempts to develop vaccines for COVID-19 and help us end the outbreak. The pandemic isn't over yet, but Moderna and Novavax have given up substantial chunks of their value in the past year. Where does that leave Moderna and Novavax?